You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Peptide inhbitors of influenza entry-FAST TRACK

    SBC: Autoimmune Technologies, LLC            Topic: NIAID

    DESCRIPTION (provided by applicant): Between 10% and 20% of the United State population suffer from seasonal influenza each year. While most individuals recover from influenza in one to two weeks, the very young, the elderly and persons with chronic medical conditions can develop post-flu pneumonia and other lethal complications. The causative agent of influenza is influenza virus, a myxovirus tha ...

    SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  2. Automated Neuron Tracing and 3D Reconstruction Software

    SBC: MICROBRIGHTFIELD, LLC            Topic: NIMH

    DESCRIPTION (provided by applicant): We propose to develop NeuroAutomatica, an innovative, automated neuron reconstruction software platform that provides analysis tools for automated quantitative analysis of neuronal structure. The software will provide multi-scalar information about multiple individual neurons in close proximity, including dendritic spines. Providing this innovative functionalit ...

    SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  3. Tissue and Airway Analysis for Emphysema Interventions

    SBC: VIDA DIAGNOSTICS, INC.            Topic: NHLBI

    DESCRIPTION (provided by applicant): With the considerable success of our phase 2 SBIR, we have achieved the completion of lung image analysis software that segments and thoroughly measures the lungs and their five lobes along with the airway tree. We have recently just achieved 510(k) FDA clearance for Pulmonary Workstation (PW 2.0) which now opens the door to the use of the Phase 2 software in t ...

    SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  4. Optimization of U1 Adaptor Technology

    SBC: INTEGRATED DNA TECHNOLOGIES, INC.            Topic: NIGMS

    DESCRIPTION (provided by applicant): Our understanding of complex biological phenomena and disease progression has led to the realization that changes in the expression of genes underlie many of these processes. Developing reagents that can selectively alter the expression level of any desired gene has been a goal of both scientists and clinicians for years. Historically, the most common approach ...

    SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  5. Camptothecin Analogs for Cancer Therapy

    SBC: DEKK-TEC INC            Topic: NCI

    DESCRIPTION (provided by applicant): 7-Butyl-10-aminocamptothecin (BACPT), as a water-soluble dipeptide pro-drug - BACPTDP, is a novel camptothecin analog that has increased activity in hypoxic/acidic tumor tissues, characteristic of fast growing cancers that characteristically have deficient vasculature and outgrow their blood supply. Both in vitro and in vivo studies support the potential useful ...

    SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  6. Automated Connective Tissue Torque Sensor

    SBC: STROMATEC, INC            Topic: NCCAM

    DESCRIPTION (provided by applicant): The long term goal of this project is to develop a biomarker - the Needle Torque Test (NTT) - capable of detecting connective tissue abnormalities associated with musculoskeletal disorders. The NTT is administered by inserting an acupuncture needle into connective tissue and using the Automated Needle Torque Sensor to deliver a precise biomechanical stimulus to ...

    SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  7. Rapid In-vivo Cancer Detection via Multispectral Confocal Cellular Imaging

    SBC: Omega Optical Incorporated            Topic: NCI

    DESCRIPTION (provided by applicant): A fast, cost-effective multispectral confocal imaging capability for high-resolution mapping in vivo will be created during this project. This new approach will be based on fiber Bragg gratings, a technology not utilized previously in biomedical imaging, and will ultimately enable the early in vivo detection and treatment of cancer at the cellular level. The c ...

    SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  8. System for comprehensive tracking and analysis of C. elegans behaviors

    SBC: MICROBRIGHTFIELD, LLC            Topic: NIEHS

    DESCRIPTION (provided by applicant): We propose a commercial product composed of a computerized microscope system that allows investigators to perform automated, quantitative analyses of locomotory and other complex behaviors of freely moving C. elegans nematodes. Using the soil nematode, C. elegans, as a practical and efficient model in toxicology studies requires creation of automated technologi ...

    SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  9. Development of a Humanized Pig Model of Cystic Fibrosis

    SBC: EXEMPLAR GENETICS, LLC            Topic: NHLBI

    DESCRIPTION (provided by applicant): Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The CFTR gene encodes a chloride channel that regulates ion flow across epithelial cell membranes. Most CF patients have a mutation that deletes phenylalanine 508 (?F508) and prevents CFTR from being properly processed and delivered to cell membra ...

    SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  10. Development of Multivalent Vaccines Against Yellow Fever and Arena Viruses

    SBC: BIOPROTECTION SYSTEMS CORP.            Topic: NIAID

    DESCRIPTION (provided by applicant): Indigenous population, travelers and troops present in Africa and South America are clearly at risk of exposure to several arenaviruses. Several human pathogenic arenaviruses, e.g., Lassa and Junin viruses, are listed on the NIAID's Priority Pathogens and CDC's Bioterrorism Agents Lists and can cause a deadly hemorrhagic fever. No effective and safe vaccine is ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government